Pathology of the bone marrow and spleen in a case of myelodysplastic/myeloproliferative neoplasm associated with t(8;9)(p22;p24) involving PCM1 and JAK2 genes

被引：10

作者：

Dargent, Jean-Louis ^{[1
]}

Mathieux, Valerie ^{[2
]}

Vidrequin, Sebastien ^{[1
]}

Deghorain, Xavier ^{[1
]}

Vannuffel, Pascal ^{[1
]}

Rack, Katrina ^{[1
]}

机构：

[1] Inst Pathol & Genet, B-6041 Gosselies, Belgium

[2] Clin St Elizabeth, Serv Hematol, Namur, Belgium

来源：

EUROPEAN JOURNAL OF HAEMATOLOGY | 2011年 / 86卷 / 01期

关键词：

PCM1-JAK2; FUSION; TRANSLOCATION; LEUKEMIA; DISORDERS;

D O I：

10.1111/j.1600-0609.2010.01525.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：87 / 90

页数：4

共 12 条

[1] A t(8;9) translocation with PCM1-JAK2 fusion in a patient with T-cell lymphoma [J].

Adélaïde, J ;

Pérot, C ;

Gelsi-Boyer, V ;

Pautas, C ;

Murati, A ;

Copie-Bergman, C ;

Imbert, M ;

Chaffanet, M ;

Birnbaum, D ;

Mozziconacci, MJ .

LEUKEMIA, 2006, 20 (03) :536-537

[2]

[Anonymous], 2008, WHO CLASSIFICATION T

[3] The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukaemia yields a new PCM1-JAK2 fusion gene [J].

Bousquet, M ;

Quelen, C ;

De Mas, V ;

Duchayne, E ;

Roquefeuil, B ;

Delsol, G ;

Laurent, G ;

Dastugue, N ;

Brousset, P .

ONCOGENE, 2005, 24 (48) :7248-7252

[4] Myelodysplastic/myeloproliferative disease with erythropoietic hyperplasia (erythroid preleukemia) and the unique translocation (8;9)(p23;p24): first description of a case [J].

Heiss, S ;

Erdel, M ;

Gunsilius, E ;

Nachbaur, D ;

Tzankov, A .

HUMAN PATHOLOGY, 2005, 36 (10) :1148-1151

[5] Evolutional change of karyotype with t(8;9)(p22;p24) and HLA-DR immunophenotype in relapsed acute myeloid leukemia [J].

Huang, Kuan-Po ;

Chase, Andrew J. ;

Cross, Nicholas C. P. ;

Reiter, Andrea ;

Li, Tzu-Ying ;

Wang, Tso-Fu ;

Chu, Sung-Chao ;

Lu, Xuan-Yin ;

Li, Chi-Cheng ;

Kao, Ruey-Ho .

INTERNATIONAL JOURNAL OF HEMATOLOGY, 2008, 88 (02) :197-201

[6] Expression of TEL-JAK2 in primary human hematopoietic cells drives erythropoietin-independent erythropoiesis and induces myelofibrosis in vivo [J].

Kennedy, J. A. ;

Barabe, F. ;

Patterson, B. J. ;

Bayani, J. ;

Squire, J. A. ;

Barber, D. L. ;

Dick, J. E. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (45) :16930-16935

[7] PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocation [J].

Murati, A ;

Gelsi-Boyer, V ;

Adélaïde, J ;

Perot, C ;

Talmant, P ;

Giraudier, S ;

Lodé, L ;

Letessier, A ;

Delaval, B ;

Brunel, V ;

Imbert, M ;

Garand, R ;

Xerri, L ;

Birnbaum, D ;

Mozziconacci, M ;

Chaffanet, M .

LEUKEMIA, 2005, 19 (09) :1692-1696

[8] Numerical gain and structural rearrangements of JAK2, identified by FISH, characterize both JAK2617V>F-positive and -negative patients with Ph-negative MPD, myelodysplasia, and B-lymphoid neoplasms [J].

Naifeld, Vesna ;

Cozza, Amanda ;

Berkofsy-Fessler, Windy ;

Prehal, Josef ;

Scalise, Angela .

EXPERIMENTAL HEMATOLOGY, 2007, 35 (11) :1668-1676

[9] Chromosome 9p24 abnormalities: prevalence, description of novel JAK2 translocations, JAK2V617F mutation analysis and clinicopathologic correlates [J].

Patnaik, Mrinal M. ;

Knudson, Ryan A. ;

Gangat, Naseema ;

Hanson, Curtis A. ;

Pardanani, Animesh ;

Tefferi, Ayalew ;

Ketterling, Rhett P. .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 84 (06) :518-524

[10] The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2 [J].

Reiter, A ;

Walz, C ;

Watmore, A ;

Schoch, C ;

Blau, I ;

Schlegelberger, B ;

Berger, U ;

Telford, N ;

Aruliah, S ;

Yin, JA ;

Vanstraelen, D ;

Barker, HF ;

Taylor, PC ;

O'Driscoll, A ;

Benedetti, F ;

Rudolph, C ;

Kolb, HJ ;

Hochhaus, A ;

Hehlmann, R ;

Chase, A ;

Cross, NCP .

CANCER RESEARCH, 2005, 65 (07) :2662-2667

← 1 2 →